Cancer Treatment Research in North Carolina
Cancer Treatment Research (93.395) awarded $188 million to recipients in North Carolina in 158 grants from fiscal 2021 to 2025, 3.4% of the program's national total. Duke University received the most, $72.6 million.
- Awarded in North Carolina$188 million
- Awards158
- Share of the program3.4%
- Rank among states9th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 66 | $34.8 million |
| FY 2022 | 84 | $37.5 million |
| FY 2023 | 88 | $38.3 million |
| FY 2024 | 85 | $36.7 million |
| FY 2025 | 75 | $40.6 million |
Recipients in North Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Duke University | Colleges and universities | 58 | $72.6 million |
| University of North Carolina at Chapel Hill | Colleges and universities | 45 | $60.5 million |
| Wake Forest University Health Sciences | Colleges and universities | 14 | $15.9 million |
| North Carolina State University | Colleges and universities | 3 | $6.1 million |
| Civatech Oncology, Inc. | Small businesses | 2 | $4.2 million |
| Focal Medical, Inc. | Small businesses | 1 | $4.0 million |
| Deep Creek Pharma LLC | Small businesses | 3 | $2.9 million |
| University of North Carolina at Charlotte | Colleges and universities | 4 | $2.8 million |
| Mucommune LLC | Small businesses | 3 | $2.6 million |
| Lamassu Bio Inc | Small businesses | 1 | $2.0 million |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 45 on the program page
Questions people ask
How much Cancer Treatment Research money goes to North Carolina?
$188 million from fiscal 2021 to 2025, across 158 awards. North Carolina ranks 9th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in North Carolina?
The largest recipient is Duke University, with $72.6 million in 58 awards. Next are University of North Carolina at Chapel Hill and Wake Forest University Health Sciences.
Can organizations in North Carolina apply now?
Yes, 45 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in North Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- USAID Foreign Assistance for Programs Overseas
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States